Constituye una explicación detallada de los siete principios del hermetismo. Un libro particularmente interesante para las personas que están buscando respuestas profundas a las interrogantes de la existencia, más allá del mundo fenomenológico.
Oracle BI EE has a nice feature, called Act As.
Setting this up and applying is a techy trick, where (as usual) the devil is in the details and (as usual) the Oracle Documentation has room for improvement.
This document describes it to the letter.
En esta presentación te hablo de como hallar el dominio de la función irracional de índice par, es decir de la raíz cuadrada o cuarta o sexta o... cualquier raíz pero de índice par
UNDERSTANDING THE DYNAMICS OF SUCCESSFUL HEALTH SYSTEM STRENGTHENING INTERVEN...HFG Project
This brief summarizes the results from cross-case analysis of five
retrospective, qualitative case studies of successful USAID-funded
health systems strengthening (HSS) interventions
Summary Various industries, including health care, have adop.docxpicklesvalery
Summary
Various industries, including health care, have adopted quality
improvement (QI) to enhance practices and outcomes. As
demands on the U.S. public health system continue to increase,
QI strategies may play a vital role in supporting the system and
improving outcomes. Therefore, public health practitioners, like
leaders in other industries, are developing QI approaches for
application in public health settings.
Quality improvement in public health involves systematically
evaluating public health programs, practices, and policies and
addressing areas that need to be improved to increase healthy
outcomes. Although QI methods and techniques have only
recently been applied to public health, public health systems offer
a wide range of opportunities for implementing, managing, and
evaluating QI efforts.
The growing field of Public Health Systems and Services Research
(PHSSR) offers the potential to contribute to and support QI efforts
in public health. PHSSR examines the delivery of public health
services within communities as well as the outcomes that result from
dynamic interactions within the public health system. By examining
the public health system, stakeholder interactions, delivery of services,
and outcomes, PHSSR can inform and support the implementation
of QI initiatives.
Most recently, national, state, and local levels have made notable
progress in quality improvement in public health.1, 2 One initia-
tive credited with achieving progress is the Multi-State Learning
Collaborative (MLC). The MLC aims to inform the national accredi-
tation program, incorporate quality improvement practice into pub-
lic health systems, promote collaborative learning across states and
partners, and expand the knowledge base in public health.
Bringing together state and local practitioners and other stakeholders
in a community of practice to achieve MLC goals has yielded several
best practices and lessons for public health stakeholders. However,
more work is needed if QI is to become standard practice in public
health—particularly in understanding health departments’ readiness
for change, building the evidence base for effective public health QI
practices in the context of the public health system, and examining the
sustainability of successful projects, and identifying the determinants
of transformational change.
ÆResearchInsights
Quality Improvement in Public Health: Lessons Learned
from the Multi-State Learning Collaborative
Background: AcademyHealth’s 2009 Annual Research Meeting
At the 2009 Annual Research Meeting (ARM), June 28–30, in Chicago, AcademyHealth convened a panel of three experts, members of the
Multi-State Learning Collaborative (MLC), to discuss their experiences in implementing quality improvement collaboratives in public health.
Leslie Beitsch, M.D., J.D., associate dean for health affairs and professor of family medicine and rural health at the College of Medicine, Florida
State ...
SWK 421 Research & Statistical Methods in Social WorkResearch.docxssuserf9c51d
SWK 421: Research & Statistical Methods in Social Work
Research Review - Article Analysis Form
Your Name (list all responses on the line below the information requested- this document is constructed using a table format and the line (box) will expand to the space needed as you type)
Article citation in APA Style
1. Research question(s ) and/ or hypothesis(es)
2. Independent variable(s) and operational definition(s) (i.e. what is the IV and how is it measured -- what is known about the validity and reliability of the measure(s))
3. Dependent variable(s) and operational definition(s) (What is the DV and how is it measured -- what is known about the validity and reliability of the measure(s))
4. Other variables: controlling or intervening (modifying) variables (what other variables are being assessed and measured and what is known about validity and reliability of those measures -- for example. age might be a modifying variable- other variables that are important to the question and may modify or intervene between the main IV and DV)
5. Sample (who were the participants, what was the type of sample (purposive, non-purposive), how was the sample constructed (size and characteristics), how were participants recruited)
6. Data collection (methods and procedures – the how, when, where, and by whom were study data collected)
7. Research design (what was the type of research design used- true experiment, quasi-experiment, survey, secondary data analysis, etc. are there issues regarding the validity of the design)
8. Data analysis (how were the data were analyzed- list the analysis conducted or the statistics that were used)
9. Findings/ Results (briefly discuss the findings of the research – you report findings/ results here and discuss them below)
10. Discussion (of the findings/results – what did they find, was it significant)
11. Ethical issues/ Policy implications (specified/ implied or not)
12. Research implications (what are the implications and the next logical research steps for the research (what at the implications for the field the research represents and what are next steps)
13. Strengths of the research (1 paragraph based on what you learned from the information above that strengthens you confidence in the research- the space below is double-spaced)
14. Weaknesses, issues or concerns of the research (1 paragraph based on what you learned from the information above that may limit your confidence in the study- the space below is double-spaced)
3
SWK 421 2018
Project Evaluation Rubric
Component
Exemplary (3)
Adequate (2)
Inadequate (1)
Score
Project overview
Effectively and insightfully develops a set of testable, supportable and impactful study hypotheses.
Develops a set of testable and supportable hypotheses.
Hypotheses are not testable or justifiable.
Justification for hypotheses
The introduction section provides a cogent overview of conceptual and theoretical issues related to the study hypotheses. Demonstrate ...
Evidence-Informed Public Health Decisions Made Easier: Take it one Step at a ...Health Evidence™
An afternoon workshop - held in partnership with the National Collaborating Centre for Methods and Tools - at the Ontario Public Health Convention April 7, 2011
Interested in learning how to evaluate your policy influence?
Do you promote the uptake and dissemination of population health interventions? Are you interested in exploring public health–related case studies of policy influence? The Guide to Policy-Influence Evaluation can help!
This guide was developed by the Public Health Agency of Canada’s Innovation Strategy and produced by Cathexis Consulting.
How can the Guide to Policy-Influence Evaluation help you?
The Guide to Policy-Influence Evaluation was developed to help organizations use policy influence to improve the uptake and evaluation of evidence-based population health interventions. This process is divided into the four steps of evaluation planning. Each step includes two or more resources to support it. The resources are then summarized and important highlights are presented as they related to each step.
This webinar includes an overview of the Guide by its developers, followed by a presentation from a community based organization who evaluated the impact on policies within their work to promote healthier weights.
The Guide to Policy-Influence Evaluation includes three public health–related case studies:
•Healthy weights among Aboriginal children and youth
•Anti-bullying for primary schools
•Food security and healthy weights
To see the summary statement of this method developed by NCCMT, click here: http://www.nccmt.ca/resources/search/241
The National Collaborating Centre for Methods and Tools is funded by the Public Health Agency of Canada and affiliated with McMaster University. The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.
NCCMT is one of six National Collaborating Centres (NCCs) for Public Health. The Centres promote and improve the use of scientific research and other knowledge to strengthen public health practices and policies in Canada.
Agenda SettingA key aspect of the policy process is agendacheryllwashburn
Agenda Setting
A key aspect of the policy process is agenda setting. How do topics get on that agenda? Agenda setting requires the support of stakeholders to move the issue forward. In this week's media presentation, Dr. Kathleen White outlines the policy process and discusses how to move issues into the policy arena through agenda setting. The ultimate goal is to gain the attention of leadership whether at the organizational, local, state, national, or international level.
To prepare:
Review this week’s media presentation, focusing on the insights shared by Dr. White and Dr. Stanley on agenda setting and identification of stakeholders.
Brainstorm clinical practice issues that you believe are worthy of being on your organization’s systematic agenda.
Who are the stakeholders who would be interested in this clinical practice issue?
By tomorrow 03/14/2018 3pm, write a minimum of 550 words in APA format with at least 3 scholarly references from the list of required readings below. Include the level one headings as numbered below”
Post
a cohesive response that addresses the following:
1) In the first line of your posting, identify the clinical practice issue you would like to see on your organization’s systematic agenda.
2) What strategies would you use to inform stakeholders and persuade them of the importance of your identified clinical practice issue?
Required Readings
Hyder, A., Syed, S., Puvanachandra, P., Bloom, G., Sundaram, S., Mahmood, S., ... Peters, D. (2010). Stakeholder analysis for health research: case studies from low- and middle-income countries. Public Health, 124(3), 159–166.
This study demonstrates how the engagement of stakeholders in research and policy making can assist in the successful implementation of policy proposals. The authors propose that by engaging stakeholders, researchers and policy makers are provided with multiple perspectives on proposed policies, which can lead to greater success with policy adoption and implementation.
Lavis, J. N., Permanand, G., Oxman, A. D., Lewin, S., & Fretheim, A. (2009). SUPPORT Tools for evidence-informed health Policymaking (STP) 13: Preparing and using policy briefs to support evidence-informed policymaking. Health Research Policy & Systems, 71–79. doi: 10.1186/1478-4505-7-S1-S13
The purpose of a policy brief is to communicate an issue clearly and definitively to policy makers. The authors of this article propose an outline for policy briefs and also stress the importance of using research when creating a policy brief.
Lowery, B. (2009). Obesity, bariatric nursing, and the policy process: The connecting points for patient advocacy. Bariatric Nursing & Surgical Patient Care, 4(2), 133–138.
This article provides an example of nurse involvement in policy making by examining a bariatric nursing issue. The author stresses that nurses, in their patient-advocacy role, have a responsibility to be involved in the health care ...
Using Data, Transforming Practice: Evaluating Mental Health Transformation in...MHTP Webmastere
Using Data, Transforming Practice: Evaluating Mental Health Transformation in Washington State</strong><br />
This presentation, made in February 2008 to the 18th Annual Conference on State Mental Health Agency Services
Research, details the approach of the Mental Health Transformation Project in using data to evaluate transformation
Leveraging Public Health Capacity to Increase Health System EfficiencyNASHP HealthPolicy
Presenter Sharon Moffatt Chief of Health Promotion and Disease Prevention with the Association of State and Territorial Health Officials, leading on prevention, access to care and health reform
Exploring Disparities Using New and Updated MEasures on SHADAC's State Health...soder145
Slides from webinar webinar introducing two new measures of health outcomes and social determinants of health on SHADAC’s State Health Compare—Unhealthy Days and Unaffordable Rents. This presentation, hosted by SHADAC researchers Brett Fried and Robert Hest, examine these new measures and highlight how the estimates can be used to explore disparities between states and among sub-populations.
Leveraging 1332 State Innovation Waivers to Stabilize Individual Health Insur...soder145
Presentation by SHADAC Senior Research Fellow Emily Zylla at the 2018 Association for Public Policy Analysis & Management (APPAM) Fall Research Meeting in Washington, DC.
Modeling State-based Reinsurance: One Option for Stabilization of the Individ...soder145
Presentation by SHADAC Director Lynn Blewett at the 2018 Association for Public Policy Analysis and Management (APPAM) Fall Research Conference in Washington, DC.
2017 Health Insurance Coverage Estimates: SHADAC Webinar Featuring U.S. Censu...soder145
Join us for an overview of the 2017 health insurance coverage estimates from two key, large-scale federal data sources: The American Community Survey (ACS) and the Current Population Survey (CPS).
This webinar will examine the new estimates with technical insight from experts at the U.S. Census Bureau, which administers both the ACS and CPS, and from SHADAC researchers.
Attendees will learn about:
The new 2017 national and state coverage estimates
When to use which estimates from which survey
How to access the estimates via Census reports and American FactFinder
How to access state-level estimates from the ACS using SHADAC tables
SHADAC researchers and Census experts will answer questions from attendees after the presentation.
Exploring the New State-Level Opioid Data On SHADAC's State Health Comparesoder145
Between 2000 and 2016, the annual number of drug overdose deaths in the United States more than tripled, from 17,500 to 63,500, and most of these deaths involved opioids. Despite widespread increases in overdose death rates from natural and semi-synthetic opioids, synthetic opioids, and heroin, individual states’ death rates varied widely. For example, in 2016, Nebraska’s rate of 1.2 deaths per 100,000 people was the lowest in the U.S. for natural and semi-synthetic opioids, while West Virginia’s rate (the highest) was more than 15 times larger, at 18.5 deaths. These deaths are the most glaring indication of the growing crisis of opioid abuse and addiction that has been spreading unevenly throughout the country over the past two decades.
On this SHADAC webinar, Research Fellow Colin Planalp will examine the United States opioid epidemic at the state level, analyzing trends in overdose deaths from heroin and other opioids, such as prescription painkillers. Using data available through SHADAC’s State Health Compare, he will look at which states have the highest rates of opioid-related deaths and which have experienced the largest increases in death rates.
Mr. Planalp will be joined by SHADAC Research Fellow Robert Hest, who will discuss the data on opioid-related overdose deaths from the U.S. Centers from Disease Control and Prevention (CDC) that are available on SHADAC’s State Health Compare. He will also discuss State Health Compare data from the U.S. Drug Enforcement Administration (DEA) on sales of common prescription opioid painkillers. Mr. Hest will show users how to access and use the data for state-level analyses.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
State Health Access Reform Evaluation: Building the Evidence for Reform
1. State Health Access Reform Evaluation:Building the Evidence for Reform Elizabeth Lukanen SHADAC/SHARE University of Minnesota State Coverage Initiatives Annual Meeting Albuquerque, NM Friday, July 31, 2009
2. 2 State Health Access Reform Evaluation (SHARE) National Program Office of the RWJF Co-located with the State Health Access Data Assistance Center (SHADAC) Provide technical assistance to states on program evaluation and assessment Goals Fund and coordinate evaluations of state health reform Fill gaps on research to identify what works and why Organize and disseminate findings in a manner that is meaningful to state and national policy-makers
5. 4 If States Are Policy Laboratories:Where Are the Lab Reports? Evaluation of state health reform has largely consisted of specific case studies Difficult to compare the lessons of reform across states or across different mechanisms Need a uniform reform evaluation framework to identify what works and why
6. Evaluations Provide Value to the Policy Process Justify program budget/financing Satisfy legislative requirements Identify successful initiatives Change course if program not meeting benchmarks Inform state and national debate on health reform What works at the state level? 5
15. 9 State Involvement is Critical Must be more than a nominal partnership State should be involved at every stage from research design to reviewing results Involvement is facilitated by personal contacts Healthy tension between maintaining objectivity and building necessary relationships
16. Results Timeline SHARE grants awarded in spring 2008 Early results released 2009/2010 National Academy of State Policy (Fall ‘09) Association of Public Policy and Planning (Evidenced Based Policy Making in the Post-Bush/Clinton Era - Fall ‘09) Series of Issue Briefs as results become available Topical webinar starting in fall ‘09 Special Issue: Journal of Health Services Research (web articles available in 2010) 10
17. 11 SHADAC & SHARE as a Resource Bridging the gap between research and policy SHADAC and SHARE provide: Technical assistance on using data for state health policy research Resources and information on state survey methods Facilitation of health policy research Support for the evaluation of state health reform Synthesis of state health reform initiatives Technical assistance to inform health policy research